New Delhi: Eugia Pharma Specialities Limited, a wholly owned subsidiary of Aurobindo Pharma Limited, has launched Pomalidomide Capsules, 1 mg, 2 mg, 3 mg and 4 mg, in the US…

New Delhi: India's apex drug regulator, the Central Drugs Standard Control Organization (CDSCO), has issued a public advisory following the reported theft of a batch of the insulin product Lantus…

Panaji: The Goa government has blacklisted a pharmaceutical company following a controversy over the alleged supply of suspicious anti-snake venom to the Directorate of Health Services (DHS), triggering an investigation…

Hyderabad: NATCO Pharma Limited, in partnership with Breckenridge Pharmaceutical, Inc., has announced the launch of Pomalidomide Capsules in the United States, a generic version of Pomalyst marketed by Celgene. Pomalidomide,…

Chennai: Caplin Steriles Limited, a wholly owned subsidiary of Caplin Point Laboratories Limited, has received final approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug…

Glucagon-like peptide-1 (GLP-1) receptor agonists used to treat type 2 diabetes and obesity may also help to lower the risk of addiction to a range of substances including alcohol, cannabis,…

New Delhi: The expiry of semaglutide's key patent in India in March 2026 is ushering in a tsunami of generic versions of the blockbuster diabetes and weight-loss molecule, leading to…

China: A new study published in BMC Surgery suggests that intramedullary nailing may offer faster recovery and improved functional outcomes compared with dual-plate fixation in selected patients with proximal humeral…

A first-in-human, phase I single-arm trial has found that in-utero treatment of myelomeningocele, the most severe form of spina bifida, using allogeneic live stem cells was both feasible and safe.…

New Delhi: Emcure Pharmaceuticals has announced the signing of a distribution agreement with Roche for select products in the nephrology and transplant medicine portfolio, marking a significant step toward expanding…